Government Research Institute

Updated:

National Human Genome Research Institute

NHGRI was established in 1989 as the National Center for Human Genome Research, becoming an institute in 1997.

National Human Genome Research Institute

NHGRI was established in 1989 as the National Center for Human Genome Research, becoming an institute in 1997. Eric Green, a physician-scientist who trained under Francis Collins, took the director role in 2009. The institute's wealth origin is federal appropriations through the NIH budget, not private capital. The institute allocates its budget primarily to extramural research grants, intramural research programs, and the development of genomic technologies. It funds large-scale sequencing centers, including the Broad Institute and the Wellcome Sanger Institute, and supports projects like the Encyclopedia of DNA Elements (ENCODE) and the Human Genome Reference Program. Its geographic footprint is global, with funded research in North America, Europe, and Asia. NHGRI employs a professional staff of roughly 400 across its Bethesda campus and additional NIH facilities. The institute operates the Intramural Research Program, which conducts investigator-initiated research in genomic medicine, computational biology, and molecular genetics. In fiscal year 2024, NHGRI's budget was approximately $650 million (per NIH public data, 2024). NHGRI's structural differentiator is its mandate as a government institute uniquely dedicated to genomics—a mission that separates it from private research entities. Its funding flows through the NIH peer-review system, prioritizing open-access data sharing over proprietary returns. The institute has no succession structure typical of family offices, instead operating under federal leadership transitions.

Website
genome.gov

General information

Firm type

Government Research Institute

Year founded

1989

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Bethesda

Corporate office

Bethesda, MD, United States

Principals

Eric Green

Director

Sector focus

BiotechHealthcare Services

Frequently asked questions

Who runs investment decisions at NHGRI?

Investment decisions at NHGRI are made through the NIH peer-review system. The institute's director, Eric Green, sets strategic priorities, but grant funding is allocated by external scientific reviewers. Intramural research decisions flow through institute leadership, guided by the NIH scientific mission.

How does NHGRI source proprietary deal flow?

NHGRI does not engage in proprietary deal flow. It funds research through competitive grants and operates an intramural program. Its 'deal flow' is based on investigator-initiated proposals and institute-identified scientific priorities, not market opportunities.

Is NHGRI structured as a single family office or does it operate more like a venture firm?

NHGRI is a federal government research institute under the National Institutes of Health. It operates as a grant-making and research organization, with no resemblance to a family office or venture firm.

Does NHGRI participate in fund commitments or only direct deals?

NHGRI does not participate in fund commitments or direct deals. It provides grants and contracts to academic and research institutions for genomic science. It holds no private investment portfolio.

What investment stages does NHGRI typically target?

NHGRI does not target investment stages. Its funding spans basic research through clinical translation, but it does not invest in equity or debt instruments.

How is NHGRI related to other NIH institutes?

NHGRI is one of 27 institutes and centers at the National Institutes of Health. It collaborates with other institutes on cross-cutting genomic initiatives but operates with its own budget and strategic plan.

Where does the underlying wealth come from?

NHGRI's funding comes from the US federal budget, appropriated by Congress through the NIH. There is no private wealth origin.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo